Published in Adv Eng Mater on May 07, 2012
Sample dimensions influence strength and crystal plasticity. Science (2004) 8.77
Mechanical annealing and source-limited deformation in submicrometre-diameter Ni crystals. Nat Mater (2007) 5.17
In situ observation of dislocation nucleation and escape in a submicrometre aluminium single crystal. Nat Mater (2009) 2.30
Ultrahigh strength single crystalline nanowhiskers grown by physical vapor deposition. Nano Lett (2009) 2.02
Ideal pure shear strength of aluminum and copper. Science (2002) 1.86
In situ nanocompression testing of irradiated copper. Nat Mater (2011) 1.71
Fundamental differences in mechanical behavior between two types of crystals at the nanoscale. Phys Rev Lett (2008) 1.52
Correlation between critical temperature and strength of small-scale bcc pillars. Phys Rev Lett (2009) 1.38
Surface-controlled dislocation multiplication in metal micropillars. Proc Natl Acad Sci U S A (2008) 1.21
Source truncation and exhaustion: insights from quantitative in situ TEM tensile testing. Nano Lett (2011) 1.11
Fabrication and microstructure control of nanoscale mechanical testing specimens via electron beam lithography and electroplating. Nano Lett (2010) 1.07
Dislocation-source shutdown and the plastic behavior of single-crystal micropillars. Phys Rev Lett (2008) 1.02
Point defect clusters and dislocations in FIB irradiated nanocrystalline aluminum films: an electron tomography and aberration-corrected high-resolution ADF-STEM study. Microsc Microanal (2011) 0.89
In situ nanomechanical testing in focused ion beam and scanning electron microscopes. Rev Sci Instrum (2011) 0.84
Mechanical annealing and source-limited deformation in submicrometre-diameter Ni crystals. Nat Mater (2007) 5.17
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci (2008) 2.39
The nanostructured origin of deformation twinning. Nano Lett (2012) 2.13
The motor neuron response to SMN1 deficiency in spinal muscular atrophy. Muscle Nerve (2014) 2.02
Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet A (2004) 1.64
Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 1.45
Experience with the Awaji Island modifications to the ALS diagnostic criteria. Muscle Nerve (2010) 1.43
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther (2011) 1.42
Wolff-Parkinson-White syndrome in Patients With MELAS. Arch Neurol (2007) 1.29
Nanocrystal diffusion in a liquid thin film observed by in situ transmission electron microscopy. Nano Lett (2009) 1.23
Missed opportunities for duchenne muscular dystrophy. J Pediatr (2009) 1.21
Strong interlayer coupling in van der Waals heterostructures built from single-layer chalcogenides. Proc Natl Acad Sci U S A (2014) 1.19
Common data elements for clinical research in Friedreich's ataxia. Mov Disord (2012) 1.14
Reducing deformation anisotropy to achieve ultrahigh strength and ductility in Mg at the nanoscale. Proc Natl Acad Sci U S A (2013) 1.10
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. PLoS One (2012) 1.08
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol (2011) 1.08
Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J Neurol Sci (2004) 1.07
Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol (2009) 1.07
Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females. Arch Neurol (2010) 1.06
Spinal muscular atrophy. Neurotherapeutics (2008) 1.06
Increased water retention in polymer electrolyte membranes at elevated temperatures assisted by capillary condensation. Nano Lett (2007) 1.04
Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol (2005) 1.03
Carrier testing for spinal muscular atrophy. Genet Med (2010) 1.02
Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol (2005) 1.01
Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy. Neuromuscul Disord (2009) 1.01
A nanoscale shape memory oxide. Nat Commun (2013) 0.98
Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. PLoS One (2012) 0.95
Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers. Neurology (2014) 0.94
Scoliosis surgery in children with neuromuscular disease: findings from the US National Inpatient Sample, 1997 to 2003. Arch Neurol (2010) 0.94
Efficiency perspectives on adaptive designs in stroke clinical trials. Stroke (2011) 0.94
Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.93
Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol (2002) 0.88
Clinical outcome measures in spinal muscular atrophy. J Child Neurol (2009) 0.88
Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet A (2009) 0.88
Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscul Disord (2010) 0.87
Therapeutic developments in spinal muscular atrophy. Ther Adv Neurol Disord (2010) 0.87
A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol (2004) 0.87
Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. J Child Neurol (2010) 0.86
Infrastructure resources for clinical research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.85
Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy. J Child Neurol (2011) 0.85
Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab (2011) 0.85
Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Arch Neurol (2010) 0.83
Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am (2003) 0.83
Minimization of focused ion beam damage in nanostructured polymer thin films. Ultramicroscopy (2010) 0.83
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. PLoS One (2007) 0.83
SMA-MAP: a plasma protein panel for spinal muscular atrophy. PLoS One (2013) 0.82
In situ formed Si nanoparticle network with micron-sized Si particles for lithium-ion battery anodes. Nano Lett (2013) 0.82
Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscul Disord (2010) 0.82
Independent mobility after early introduction of a power wheelchair in spinal muscular atrophy. J Child Neurol (2012) 0.81
A novel tRNA(Val) mitochondrial DNA mutation causing MELAS. J Neurol Sci (2008) 0.81
Web-based data management for a phase II clinical trial in ALS. Amyotroph Lateral Scler (2009) 0.81
Neuroscience networking: linking discovery to drugs. Neuropsychopharmacology (2012) 0.81
Age at disease onset predicts likelihood and rapidity of growth failure among infants and young children with spinal muscular atrophy types 1 and 2. J Child Neurol (2012) 0.81
Three-dimensional biomimetic mineralization of dense hydrogel templates. J Am Chem Soc (2009) 0.81
In situ indentation of nanoporous gold thin films in the transmission electron microscope. Microsc Res Tech (2009) 0.80
Effect of ion distribution on conductivity of block copolymer electrolytes. Nano Lett (2009) 0.80
On demand shape-selective integration of individual vertical germanium nanowires on a Si(111) substrate via laser-localized heating. ACS Nano (2013) 0.79
Synthesis of hierarchical TiO2 nanowires with densely-packed and omnidirectional branches. Nanoscale (2013) 0.79
Void formation induced electrical switching in phase-change nanowires. Nano Lett (2008) 0.79
Learning to walk: challenges for spinal muscular atrophy clinical trials. Neurology (2007) 0.79
Commonalities and challenges in the development of clinical trial measures in neurology. Neurotherapeutics (2015) 0.78
Bioelectrical impedance analysis can be a useful screen for excess adiposity in spinal muscular atrophy. J Child Neurol (2010) 0.78
In situ TEM near-field optical probing of nanoscale silicon crystallization. Nano Lett (2012) 0.78
Motor Unit Estimate Number in the Anterior Tibial Muscle: Normative Data versus Findings in Critically Ill Patients in Intensive Care Units. J Clin Neuromuscul Dis (2002) 0.77
Randomized control trials in ALS: lessons learned. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 0.77
ALS Research Group (ALSRG): second meeting, a summary report. Amyotroph Lateral Scler (2006) 0.77
Fatigue leads to gait changes in spinal muscular atrophy. Muscle Nerve (2011) 0.76
Carotid intervention: is it warranted in asymptomatic individuals if risk factors are aggressively managed? Stroke (2014) 0.76
ALS treatment strikes out while trying for a homer: the topiramate trial. Neurology (2003) 0.75
Survival in SMA type 1. Neuromuscul Disord (2008) 0.75
Reply: To PMID 23893312. Muscle Nerve (2014) 0.75
Funding agencies and disease organizations: resources and recommendations to facilitate ALS clinical research. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.75
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology. Neurotherapeutics (2015) 0.75
Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy Against Breast Cancer. ACS Appl Mater Interfaces (2020) 0.75
Morphology-conductivity relationship in crystalline and amorphous sequence-defined peptoid block copolymer electrolytes. J Am Chem Soc (2014) 0.75
Cs-corrected scanning transmission electron microscopy investigation of dislocation core configurations at a SrTiO(3)/MgO heterogeneous interface. Microsc Microanal (2013) 0.75
Adding more muscle and nerve to clinical trials. Muscle Nerve (2011) 0.75
Small-Fiber Neuropathy Associated with Capecitabine (Xeloda)-induced Hand-foot Syndrome: A Case Report. J Clin Neuromuscul Dis (2006) 0.75
Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation. Can J Neurol Sci (2005) 0.75
An integrated motion capture system for evaluation of neuromuscular disease patients. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
Deciphering the three-dimensional morphology of free-standing block copolymer thin films by transmission electron microscopy. Micron (2012) 0.75
Design and evaluation of a hybrid passive and active gravity neutral orthosis (GNO). Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
A 14-year-old male with asymptomatic proteinuria and hearing loss. Am J Kidney Dis (2003) 0.75
Superglide at an internal incommensurate boundary. Nano Lett (2010) 0.75